« Previous
Next »
Titles
- CBO's Medicare beneficiary cost-sharing model: a technical description1
- CMS's 2018 proposed Medicaid managed care rule: a summary of major provisions1
- California health insurers: large insurers remain on top1
- California's Medicaid state plan amendments1
- Californians maintain health insurance coverage despite national trends1
- Care provider facilities described challenges addressing mental health needs of children in HHS custody1
- Changes at community health centers, and how patients are benefiting1
- Changes in health coverage by race and ethnicity since implementation of the ACA: 2013-20171
- Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff1
- Child-resistant packaging statements in drug product labeling1
- Choosing providers for select services and procedures: consumers' experiences and preferences1
- Citizen petitions and petitions for stay of action subject to section 505(q) of the Federal Food, Drug, and Cosmetic Act1
- Class II special controls guideline: in vitro diagnostic devices for Bacillus spp. detection : guideline for industry and Food and Drug Administration staff1
- Classification and requirements for laser illuminated projectors (LIPs): (Laser Notice No. 57) : guidance for industry and Food and Drug Administration staff1
- Community health centers and Medicaid delivery and payment reform: a closer look at Massachusetts and New York1
- Community health centers and the President’s HIV Initiative: issues and challenges facing health centers in high-burden states and communities1
- Community health centers continue steady growth, but challenges loom1
- Comparing health insurance reform options: from "building on the ACA" to single payer1
- Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry1
- Compliance policy for limited modifications to certain marketed tobacco products1